Labomar

Major Shareholding Notification • Jun 27, 2023

NOTICE OF SUBSTANTIAL CHANGE OF SIGNIFICANT SHAREHOLDERS

CCP NO. 7.2 LIMITED exceeds the 5% threshold of Labomar S.p.A. share capital

Istrana (TV), June 27, 2023 — Labomar SpA ("Labomar" or the "Company"), (Ticker: LBM), an Italian-based international nutraceutical enterprise listed on the Euronext Growth Milan market announces, pursuant to the Transparency Regulation and art. 17 of the Euronext Growth Milan Issuers' Regulation, to have received today from the shareholder CCP NO. 7.2 LIMITED ("CCP"), communication of the exceeding of the relevance 5% threshold of Labomar share capital, following the purchase of number 508.250 ordinary shares on the Euronext Growth Milan market, which took place on 27 June 2023.

Based on the communication received, CCP currently holds 1.261.250 ordinary shares, equal to approximately 6,8% of the Company's share capital.

Based on the information reported, pursuant to art. 26 of the Euronext Growth Milan Issuers' Regulation, the Company announces that from the latest records in its possession, the current Labomar's shareholding is as follows:

Significant shareholders	Nr. of ordinary shares	% of Labomar share capital
LBM Holding S.r.l.	12.447.033	67,3%
CCP NO. 7.2 LIMITED	1.261.250	6,8%
Master Lab SA	1.143.500	6,2%
Value First SICAF S.p.A.	905.000	4,9%
Joh. Berenberg, Gossler & Co. KG	707.062	3,8%
Mercato	2.020.198	11%

For further information please see Labomar Spa website https://labomar.com/en/info-forshareholders/.

This press release is published on the website https://labomar.com/en/results-and-pressreleases/ and on platform on the site.

*****

Labomar Profile

Founded by Walter Bertin in Istrana (province of Treviso) in 1998, Labomar is specialised in the development and production of food supplements, medical devices, foods for special medical purposes and cosmetics for third parties. Over more than 20 years, Labomar has built a business model which sets it apart from its competitors and generates value for all stakeholders, providing a comprehensive service and a high quality and productivity standard. The company boasts a well-structured and cutting-edge research and development department with a particular focus on innovation, a commercial team which reacts quickly to market demands and a high level of product differentiation thanks to its proprietary patents and formulas.

Following the acquisitions of the Welcare Group and Labiotre Srl, in addition to the establishment of LaboVar Srl, in 2022 Labomar focused on maximising the synergies among the various companies, pooling resources and expertise to expand its product portfolio, enter new markets and streamline certain processes, including through the best practices brought by each of the Group companies.

Labomar whole-heartedly believes in a business system based on sustainability and a real concern for people, the environment and the community. It therefore by 2020 had gained Benefit Company status and simultaneously embarked on obtaining B Corp Certification, for which it has already applied to the relative body for certification issuance. This is testament to the company's decision to join a global movement of enterprises meeting elevated social and environmental impact standards.

For further information:

Labomar Press Office

Thanai Bernardini - +39.335.7245418 - me@thanai.it Alessandro Bozzi Valenti - +39.348.0090866 - alessandro.valenti@thanai.it Margherita Bertolo - +39.328.5574976 - margherita.bertolo@thanai.it

Investor Relations Labomar Claudio De Nadai - +39.0422.677203 - claudio.denadai@labomar.com Mara Di Giorgio - +39 335 7737417 - mara@twin.services

Euronext Growth Advisor Banca Mediolanum - +39 02 9049 2525 - ecm@mediolanum.it